跳至主要内容
临床试验/NCT05526339
NCT05526339Unknown不适用

High-Flow Nasal Oxygenation Combined With Nasopharyngeal Airway Reduces The Incidence Of Hypoxia During Gastrointestinal Endoscopy Sedated With Propofol In Obese Patients: A Prospective, Randomized Clinical Trial

RenJi Hospital2 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2022年9月最近更新:
适应症

试验速览

阶段
不适用
入组人数
600
试验地点
2
主要终点
The incidence of hypoxia

研究概览

简要总结

Obesity is associated with adverse airway events including desaturation during deep sedation. Previous studies have suggested that high-flow nasal oxygenation may be superior to regular (low-flow) nasal cannula for prevention of hypoxia during Sedated Gastrointestinal Endoscopy in non-obesity patients. The prerequisite of high-flow nasal oxygenation is keeping airway patency. Our pervious study demonstrated that nasopharyngeal airway has the similar efficacy of jaw-lift. In present study we aimed to determine whether high-flow nasal oxygenation combined with nasopharyngeal airway could reduce the incidence of hypoxia during Sedated Gastrointestinal Endoscopy in obese patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
19 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients receiving selective combined upper intestinal and lower intestinal endoscopy procedure under deep sedation.
  • Age ranging from 19 to 80, both male and female
  • Obese patients,BMI ≥ 28kg/m^2
  • Patients should clearly understand and voluntarily participate in the study, with signed informed consent.

排除标准

  • Patients with acute respiratory infection in the last 2 weeks
  • Patients with nasal congestion, epistaxis, recent nasal trauma, recent nasal surgery
  • hypoxia, defined as oxygen saturation measured by pulse oximetry (SpO2) ≤ 95% before preoxygenation.
  • Common advanced gastrointestinal endoscopy procedures meeting eligibility criteria included cholangiopancreatography, endoscopic ultrasound procedures, endoscopic mucosal resection and endoscopic retrograde cholangiopancreatography (ERCP) procedures.
  • coagulation disorders or platelets < 100*10^9/L
  • Have serious heart diseases such as severe arrhythmia, heart failure, Adams Stokes Disease, unstable angina pectoris, myocardial infarction in the last 6 months, history of tachycardia / bradycardia requiring medical treatment, third degree atrioventricular block or QTC interval ≥ 450ms (corrected according to fridericia's formula), or exercise tolerance < 4mets
  • Allergy to eggs, soy products, opioids and other drugs, propofol, etc.
  • Participated in other clinical trials as a subject within 3 months
  • Patients with brain injury, possible convulsion, myoclonus, intracranial hypertension, cerebral aneurysm, cerebrovascular accident history, schizophrenia, intellectual disability, mania, psychosis, long-term use of psychotropic drugs, drug addiction, cognitive dysfunction history, etc.
  • Emergency procedure
  • Pregnant or breast-feeding women
  • Patients having procedures with planned tracheal intubation or laryngeal mask
  • Investigator considers the patients are inappropriate to participate in this trial

结局指标

主要结局

The incidence of hypoxia

时间窗: Patients will be followed for the duration of hospital stay, an expected average of 2 hours

Hypoxia refers to 75%≤SpO2\<90%,\<60S

次要结局

  • The incidence of severe hypoxia(Patients will be followed for the duration of hospital stay, an expected average of 2 hours)
  • The incidence of subclinical respiratory depression(Patients will be followed for the duration of hospital stay, an expected average of 2 hours)
  • The incidence of other adverse events(Patients will be followed for the duration of hospital stay, an expected average of 2 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验